摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6-bromo-2-methoxy-1-naphthyl)methanol | 247174-13-6

中文名称
——
中文别名
——
英文名称
(6-bromo-2-methoxy-1-naphthyl)methanol
英文别名
6-Bromo-2-methoxynaphthalen-1-ylmethanol;(6-bromo-2-methoxynaphthalen-1-yl)methanol
(6-bromo-2-methoxy-1-naphthyl)methanol化学式
CAS
247174-13-6
化学式
C12H11BrO2
mdl
——
分子量
267.122
InChiKey
SOVDLTFOHOEBCC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Naphthalene derivatives, their production and use
    摘要:
    包含以下公式化合物的组合物: 其中A是可被取代的含氮杂环基团,R1是氢原子、可被取代的烃基团或可被取代的单环芳族杂环基团,R2是氢原子或可被取代的低级烷基团,R3、R4、R5、R6、R7、R8和R9独立地是氢原子、可被取代的烃基团、可被取代的羟基、可被取代的硫醇基、可被取代的氨基、酰基或卤素原子,其盐或前药对类固醇C17,20-裂解酶具有抑制作用,并且对于例如预防治疗原发恶性肿瘤、其转移和复发等是有用的。
    公开号:
    US06573289B1
  • 作为产物:
    参考文献:
    名称:
    Naphthalene derivatives, their production and use
    摘要:
    包含以下公式化合物的组合物: 其中A是可被取代的含氮杂环基团,R1是氢原子、可被取代的烃基团或可被取代的单环芳族杂环基团,R2是氢原子或可被取代的低级烷基团,R3、R4、R5、R6、R7、R8和R9独立地是氢原子、可被取代的烃基团、可被取代的羟基、可被取代的硫醇基、可被取代的氨基、酰基或卤素原子,其盐或前药对类固醇C17,20-裂解酶具有抑制作用,并且对于例如预防治疗原发恶性肿瘤、其转移和复发等是有用的。
    公开号:
    US06573289B1
点击查看最新优质反应信息

文献信息

  • C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors
    作者:Nobuyuki Matsunaga、Tomohiro Kaku、Akio Ojida、Toshimasa Tanaka、Takahito Hara、Masuo Yamaoka、Masami Kusaka、Akihiro Tasaka
    DOI:10.1016/j.bmc.2004.06.016
    日期:2004.8
    A series of 1- and 4-(2-naphthylmethyl)-1H-imidazoles (3 and 4) has been synthesized and evaluated as C-17,C-20-lyase inhibitors. Several 6-methoxynaphthyl derivatives showed potent C-17,C-20-lyase inhibition, suppression of testosterone biosynthesis in rats and reduction in the weight of prostate and seminal vesicles in rats, whereas most of these compounds increased the liver weight after consecutive administrations. The effect on the liver weight was removed by incorporation of a hydroxy group and an isopropyl group at the methylene bridge, as seen in (S)-28d and (S)-42. Selectivity for C-17,C-20-lyase over 11beta-hydroxylase is also discussed, and (S)-42 was found to be a more than 260-fold selective inhibitor. Furthermore, (S)-42 showed a potent suppression of testosterone biosynthesis after a single oral administration in monkeys. These data suggest that (S)-42 may be a promising agent for the treatment of androgen-dependent prostate cancer. (C) 2004 Elsevier Ltd. All rights reserved.
  • NAPHTHALENE DERIVATIVES, THEIR PRODUCTION AND USE
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1073640B1
    公开(公告)日:2005-04-13
  • ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT
    申请人:Severson Bill
    公开号:US20130085133A1
    公开(公告)日:2013-04-04
    The present disclosure relates to novel compounds of formulas (1) through (19) and to a method for treating humans infected with a virus including various respiratory viruses such as members of the Paramyxoviridae family (respiratory syncytial virus (RSV), human metapneumovirus (HMPV), human parainfluenza virus (HPIV), measles virus, and mumps virus) with a compound of formulas (1) through (19). The present disclosure also relates to a cytopathic effect (CPE)-based assay that will assess virus-induced CPE for screening of compounds for treating viral diseases or inhibiting a virus.
  • US6573289B1
    申请人:——
    公开号:US6573289B1
    公开(公告)日:2003-06-03
  • US7084149B2
    申请人:——
    公开号:US7084149B2
    公开(公告)日:2006-08-01
查看更多